Ireland – Talk Bio

Actionable Insights Powered by AI

WuXi Biologics Divests Irish Vaccine Facility to Merck for $500 Million Amid Strategic Shift

4 months ago talkbio0Tagged asset, Biological Factors, BIOSECURE, Dundalk, Facility (object), Ireland, Merck, regulatory, Sales - occupational activity, strategic shift, Vaccines, WuXi

WuXi Biologics, Merck, vaccine manufacturing facility, Dundalk, Ireland, asset sale, strategic shift, regulatory changes, Biosecure Act

Merck Acquires WuXi Biologics’ Irish Vaccine Facility in $500M Deal

4 months ago talkbio0Tagged Biological Factors, Facility (object), Ireland, Merck, pharmaceutical manufacturing, Vaccines, WuXi

Merck, WuXi Biologics, vaccine facility, Ireland, $500M deal, pharmaceutical manufacturing

Pfizer Announces Layoffs in Ireland Amid Global Cost-Cutting Efforts

7 months ago talkbio0Tagged cost-cutting, Drug Industry, Ireland, Pfizer Layoffs

Pfizer layoffs, Ireland, cost-cutting, pharmaceutical industry, job cuts

Eli Lilly Expands Irish Manufacturing with Additional $1B Investment

7 months ago talkbio0Tagged Biological Factors, Eli, Eli Lilly, expansion, Investments, Ireland, Kinsale, Limerick, Manufacture

Eli Lilly, Ireland, manufacturing expansion, biologics, pharmaceuticals, investment, Limerick, Kinsale